Suchergebnisse - "Eltayeb, Kamal"

PubPharm (6)

1

Targeting metabolic adaptive responses induced by glucose starvation inhibits cell proliferation and enhances cell death in osimertinib-resistant non-small cell lung cancer (NSCLC) cell lines

enthalten in: Biochemical pharmacology | 2024

von Eltayeb, K. | Alfieri, R. | Fumarola, C. | +12

2

Targeting glucosylceramide synthase induces antiproliferative and proapoptotic effects in osimertinib-resistant NSCLC cell models

enthalten in: Scientific reports | 2024

von La Monica, S. | Vacondio, F. | Eltayeb, K. | +16

3

Intrinsic Resistance to Osimertinib in EGFR Mutated NSCLC Cell Lines Induced by Alteration in Cell-Cycle Regulators

enthalten in: Targeted oncology | 2023

von Volta, F. | La Monica, S. | Leonetti, A. | +10

4

Intrinsic Resistance to Osimertinib in EGFR Mutated NSCLC Cell Lines Induced by Alteration in Cell-Cycle Regulators

enthalten in: Targeted oncology | 2023

von Volta, F. | La Monica, S. | Leonetti, A. | +10

5

Reprogramming of Lipid Metabolism in Lung Cancer : An Overview with Focus on EGFR-Mutated Non-Small Cell Lung Cancer

enthalten in: Cells | 2022

von Eltayeb, K. | La Monica, S. | Tiseo, M. | +2

6

CDK4/6 inhibitors improve the anti-tumor efficacy of lenvatinib in hepatocarcinoma cells

enthalten in: Frontiers in oncology | 2022

von Digiacomo, G. | Fumarola, C. | La Monica, S. | +11

1
[1]